tag:blogger.com,1999:blog-55837544642551452482024-03-13T21:33:17.006-07:00Ted Broer is not a scamRelaxinPetehttp://www.blogger.com/profile/04012284384679242207noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-5583754464255145248.post-41555430646309516692009-04-25T14:38:00.000-07:002009-04-25T15:54:32.021-07:00I repeat he is not a scam!!!<div id="yiv896947795"><div id="yiv1215187370"><div style="font-family: times new roman,new york,times,serif;" id="yiv1835950000"><div id="yiv501065724"> <div><span style="font-size:100%;">When you ask google: "Was Dr. Ted Broer ever on Oprah?" The first link that you see is <a rel="nofollow" target="_blank" href="http://media-blogs.blogspot.com/2007/07/bodybyted-and-ted-broer-are-scam.html">[http://media-blogs.blogspot.com/2007/07/bodybyted-and-ted-broer-are-scam.html</a>]. He talks about how bad Dr. Ted Broer when he says that he "lied" about on 5 thousand talk shows. Well, you should actually do some research with great attention.</span></div> <div><span style="font-size:100%;"> </span></div> <div><span style="font-size:100%;"> If you actually search on youtube or google video with search inquiries such as "Dr. Ted Broer with (Larry King, Mary Lou Retton, etc.)" you would find nothing. But here is what interesting. Look at all of the dates of when the videos were posted. It only goes as far back as 3 years. Even my favorite Fred Hammond song ("Mender of Broken Hearts" which was Fred Hammond first single that was released in 1991) was posted 1 year ago. You would think that people would at least care enough to post videos about the inauguration of President Bill Clinton around the time when the WorldWideWeb was released, but it was only posted 1 year ago. The following is sad: Even the video of the inauguration of Bill Clinton cannot be found on CNN.com. Let me be thorough, I clicked on "CNN Videos" and type in "Inauguration of Bill Clinton," and it said: </span>We did not find Video results for "inauguration of Bill Clinton".<span style="font-size:100%;"> Hold on, it doesn't stop there; click on "CNN News" and type in "Bill Clinton." What do you see? His name doesn't appear anywhere except in the sponsored ads. What does that tell you? If the man who was once President of the United States is not even mentioned on the website as a saved article then why would anyone expect some doctor to be more important than a former President? Plus, Larry King Live is one of the best talk shows throughout America while others are trying to catch up; so do you think that other talk shows would follow CNN's format or do their own? Of course, they would do their own only if there was a way to be better than them; but until then they follow. So far the only way to be better is by personality.<br /><br /> Yet there is this boy who posts a blog about how bad Ted Broer is without even looking at the clues that Dr. Ted Broer is not bad. Plus he goes out of his way to find a video that is not even posted on the most popular video-searched website (Youtube) when you type in Dr. Ted Broer's name. Also, none of those videos show anything bad about him. I'm sorry, when people are looking for a ray of hope and somebody shuns it as if they did their research, that could break somebody's heart. However, thanks to my sister she told me to organize every thought into a category. The way I remember that conversation didn't make sense, but I was convinced enough to do it all the time and when I put it into action it made my life better by 80%. In this case as a musician, I remember the dates of the videos of Tye Tribbett and Fred Hammond which is a habit that forced me to remember to look at the dates of whatever videos I look at. It's a habit because it helps me remember what I was doing at that time of year.<br /></span></div><br /> <div><span style="font-size:100%;"> Plus, we can all forgive that brother if he meant no harm and we can all move on. By the way please do listen to Mender of Broken Hearts. Seriously, only because it's that good. In addition, by far, all of the information that Dr. Ted Broer says is true (which means that there is a lot of danger in our products). I must let you know that if you sign up for his for his monthly emails then you will receive </span><span style="font-size:100%;">about 50 pages worth of</span><span style="font-size:100%;"> information with valid resources. Please do check on my myspace which is where I will do my best to summarize some of the important information in my blogs once I graduate with at least a nursing degree in 2011 before I plan to go get a masters in Diagnostics. Here is the link: http://www.myspace.com/petertoutoute<br /><br />Sign up for Dr. Ted Broer's email</span><span style="color: black;"><span style="font-family:Times New Roman;font-size:100%;"> by going to www.healthmasters.com, click on "Get FREE INFO NOW" and submit your information.</span></span><br /><span style="font-size:100%;"><br />For example, below is a list of resources for Ted Broer's email about Aspartame:<br /><br /></span> <p class="MsoNormal" style="margin-left: 0.25in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">1. Stegnik, L.; Filer, L.J. Jr. Aspartame<span style=""> </span>Marcel Dekker, Inc. 1989.</span></span></p> <p class="MsoNormal" style="margin-left: 0.25in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">2. G.D. Searle Company, Confidential Internal Memorandum Entitled Food and Drug Administration and other Drug Sweetener Strategy.<span style=""> </span>Documents supplied by Sen. Howard Metzenbaum’s office, December 28, 1970.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">3.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">STEADMAN’S Medical Dictionary, 25<sup>th</sup> edition, William and Williams, Baltimore, 1990.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">4.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Louis, R.J., Sax’s Dangerous Properties of Industrial Materials, Eighth edition, New York: Van Nostrand Reinhold, 1992, pp. 2251-2252.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">5.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">IBID</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">6.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Monte, W., Aspartame: Methanol and Public Health, J Appl Nutr 36:42-54, 1984.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">7.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Thomas-Doberson, D., “Calculation of Aspartame Intake in Children.” Journal of the American Dietetic Association 89(6): 831-833, 1989.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">8.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 44:31716-31718, June 1, 1979.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">9.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Thomas-Doberson, op set.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">10.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Koehler, S.M.; Glaros, a. “The Effect of Aspartame on Migraine Headache.” Headache 28(1): 10-13, 1988.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">11.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 38: 5921, March 5, 1973.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">12.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 39: 27317, July 25, 1985.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">13.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 46: 38285, July 24, 1981.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">14.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">U.S. Court of Appeals for the District of Columbia Circuit, No. 84-1153.<span style=""> </span>Community Nutrition Institute, et al., Petitioners v. Dr. Mark Novitch, Acting Commissioner, Food and Drug Administration, Respondent, G.D. Searle Co., Inventor, Petition for Review of an Order of the Food and Drug Administration, No. 84-5253.<span style=""> </span>Community Nutrition Institute, et al., Appellants v. Dr. Mark Novitch, Acting Commissioner, Food and Drug Administration, Appellee, September 24, 1985.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">15.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Documents supplied by Sen. Howard Metzenbaum’s office, February 6, 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">16.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 40: 56907, December 5, 1975.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">17.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Food and Drug Administration, Searle Investigation Task Force Chaired by Carlton Sharp, “Final Report of Investigation Review of G.D. Searle Company.” March 24, 1976.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">18.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 44: 31716-31718, June 1, 1979.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">19.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Letter from Richard A. Merrill, Chief Counsel, Department of Health, Education, and Welfare, Food and Drug Administration, to Honorable Samuel K. Skinner, U.S. Attorney, Northern District of Illinois, requesting that Skinner’s office convene a Grand Jury investigation into G.D. Searle Co. for submitting false reports dated January 10, 1977.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">20.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Letter from Howard J. Trienens, Sidley & Austin, to Samuel K. Skinner, U.S. Attorney, Northern District of Illinois, January 26, 1977.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">21.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Documents supplied by Sen. Howard Metzenbaum’s office, February 6, 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">22.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Confidential memorandum from Samuel K. Skinner, U.S. Attorney, Northern District of Illinois, to William Conlon and Fred Branding.<span style=""> </span>Document supplied by Sen. Howard Metzenbaum’s office, March 8, 1977.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">23.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Memorandum from Charles P. Kocoras, First Assistant U.S. Attorney, to Samuel J. Skinner, U.S. Attorney, regarding the G.D. Searle Company, April 13, 1977.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">24.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Documents supplied by Sen. Howard Metzenbaum’s office, February 6, 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">25.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Food and Drug Administration, Bressler, J., The Bressler Report, Investigation of Searle Laboratories, August 7, 1977.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">26.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Memorandum from Bureau of Foods Task Force, Food and Drug Administration, to Howard R. Roberts, Ph. D., Acting Director, Bureau of Foods, regarding “Authentication Review of Data in Reports Submitted to the Food and Drug Administration Concerning Aspartame.” September 28, 1977.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">27.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">U.S. General Accounting Office, “Briefing Report to the Honorable Howard Metzenbaum, U.S. Senate, Food and Drug Administration, Six Former HHS Employees’ Involvement in Aspartame’s Approval.” GAO/HRD-86-109BR, July 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">28.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Documents supplied by Sen. Howard Metzenbaum’s office, February 6, 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">29.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">U.S. General Accounting Office, “Report to the Honorable Howard Metzenbaum, U.S. Senate, Food and Drug Administration, Food Additive Approval Process Followed for Aspartame.” GAO/HRD-87-46, Common Cause, June 1987.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">30.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 44:31716-31718, June 1, 1979.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">31.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Food and Drug Administration Public Board of Inquiry, Nauta, W.J.H., Lampert, P.W., Young, V.R. “Aspartame (Docket No. 75F-0355): Decision of the Public Board of Inquiry.” September 30, 1980.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">32.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 48: 54993-54995, December 8, 1983, and Federal Register 46: 38288-38289, July 24, 1981.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">33.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">U.S. Court of Appeals for the District of Columbia Circuit, No. 84-1153.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">34.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Internal memoranda from three Food and Drug Administration scientists: Dr. Robert J. Condon, Dr. Satya D. Dubey and Dr. Douglas Park, to Joseph A. Levitt, Food and Drug Administration, advising against approval of NutraSweet, May 19, 1981.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">35.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 46: 38285, July 24, 1981, and Federal Register 48: 54993-54995, December 8, 1983.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">36.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Hiroyuki Ishii, “Incidence of Brain Tumors in Rats Fed Aspartame.” Life Science Laboratories, Central Research Laboratories, Ajinomoto Co., Inc., Yokohama, Japan.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">37.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Food and Drug Administration, Public Health Service, Department of Health and Human Services.<span style=""> </span>“Aspartame (Docket No. 75F-0355): Summary of Commissioner’s Decision.” July 15, 1981.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">38.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Committee on Labor and Human Resources. “NutraSweet-Health and Safety Concerns Hearing before the Committee on Labor and Human Resources, U.S. Senate, One Hundredth Congress, First Session on Examining the Health and Safety Concerns of NutraSweet (Aspartame).” November 3, 1987.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">39.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 46: 50947, October 16, 1981.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">40.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">U.S. Court of Appeals for the District of Columbia Circuit, No. 84-1153.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">41.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 47: 46140, October 15, 1982.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">42.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Food and Drug Administration, “Aspartame in Carbonated Beverages Approved.”<span style=""> </span>FDA Talk Paper, July 1, 1983.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">43.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Federal Register 48: 31376, July 8, 1983.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">44.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Congressional Record 131(58): S5489-S5517, May 7, 1985.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">45.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">IBID S5509-S5510.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">46.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">U.S. General Accounting Office. “Briefing Report to the Honorable Howard Metzenbaum, U.S. Senate: Food and Drug Administration, Six Former HHS Employees’ Involvement in Aspartame’s Approval.” GAO/HRD-86-109BR, July 1, 1983.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">47.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Graves, F., “Results of Common Cause Magazine Investigation of FDA’s Approval of Aspartame.” Common Cause, July 1984.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">48.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Centers for Disease Control, Division of Nutrition, Center for Health Promotion and Education. “Evaluation of Consumer Complaints Related to Aspartame Use.” November 1984.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">49.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">IBID</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">50.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Zaslow, J., “Searle’s John Robson to Remain in Two Posts Until After Merger.” Wall Street Journal, October 1, 1985.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">51.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">IBID</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">52.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Verrilli, G.R.; Muser, A.M., While Waiting: A Prenatal Guidebook, St. Martin’s Press, 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">53.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Documents supplied by Sen. Howard Metzenbaum’s office, February 6, 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">54.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Letter from John M. Taylor, Associate Commissioner for Regulatory Affairs, Food and Drug Administration, to James S. Turner, Swankin & Turner, denying the Community Nutrition Institute’s petition to seek administrative reconsideration of the FDA’s regulations concerning aspartame, November 21, 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">55.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Committee on Labor and Human Resources, November 3, 1987.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">56.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Letter from John M. Taylor, November 21, 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">57.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Letter from F. Owen Fields, Ph. D., Novel Ingredients Branch, Division of Product Policy, Center for Food Safety and Applied Nutrition, Department of Health and Human Services regarding “Pre-1988 Aspartame Approvals.” February 25, 1994.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">58.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">U.S. General Accounting Office, “Report to the Honorable Howard M. Metzenbaum, U.S. Senate: Food and Drug Administration, Food Additive Approval Process Followed for Aspartame.” GAO/HRD-87-46, June 1987.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">59.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Department of Health and Human Services, Health and Injury Related Surveillance Subprogram Postmarketing Surveillance System. “Quarterly Report on Adverse Reactions Associated with Aspartame Ingestion.” Submitted to Health Hazards Evaluation Board, January 2, 1987.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">60.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">U.S. General Accounting Office, “Report to the Honorable Howard M. Metzenbaum, U.S. Senate: Food and Drug Administration, Food Additive Approval Process Followed for Aspartame.” GAO/HRD-87-46, Common Cause, June 1987.</span></span></p> <p class="MsoNormal" style="margin-left: 0.25in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">61.<span style=""> </span>Testimony of Dr. Jacqueline Verrett, Food and Drug Administration Toxicologist, before the U.S.<span style=""> </span>Senate Committee on Labor and Human Resources, regarding “NutraSweet Health and Safety Concerns.” November 3, 1987.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">62.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Nutra Sweet Co., “U.S. Consumer Products Containing NutraSweet Brand Sweetener.” February 2, 1988.</span></span></p> <p class="MsoBodyTextIndent2" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">63.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Food and Drug Administration, Department of Health and Human Services. “Quarterly Report on Adverse Reactions Associated with Aspartame Ingestion.” October 1, 1988.</span></span></p> <p class="MsoNormal" style="margin-left: 0.25in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">64. Department of Health and Human Services, “Report on All Adverse Reactions in the Adverse<span style=""> </span>Reaction Monitoring System.” February 25 and 28, 1992.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">65.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Monte, W., Aspartame: Methanol and Public Health, J Appl Nutr 36: 42-54, 1984.</span></span></p> <p class="MsoBodyTextIndent3" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">66.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span>Boehm, M.F., Bada, J.L. “Racemization of aspartic acid and phenylalanine in the sweetener aspartame at 100 degrees C.” Proceedings of the National Academy of Sciences of the United States of America, 81(16): 5263-6, August 1984.</p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">67.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Walton, R.G.; Hudak, R.; Green-Waite, R.J. “Adverse Reactions to Aspartame: Double-Blind Challenge in Patients from a Vulnerable Population.” Biological Psychiatry 34: 13-17, 1993.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">68.<span style=""> </span>Walton, R.G., “Seizure and Mania After High Intake of Aspartame.” Psychosomatics, March 1986.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;"><span style=""> </span>69.<span style=""> </span>Maher, T.J., Wurtman, R.J. “Possible Neurological Effects of Aspartame, a Widely Used Food<span style=""> </span>Additive.” Environmental Health Perspectives, 75: 53-7, November 1987.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">70.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Pinto, J.M., Maher, T.J. “Administration of aspartame potentiates pentylenetetrazol-and fluorothyl-induced seizures in mice.” Neuropharmacology, 27(1):51-55, January 1988.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">71.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Roberts, H.J., Aspartame (NutraSweet): Is It Safe., The Charles Press, 1990.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">72.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Mary Nash Stoddard, Aspartame Consumer Safety Network, PO Box 780634, Dallas, TX 75378 (214) 352-4268.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">73.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Hicks, Megan.<span style=""> </span>“NutraSweet…too good to be true?”<span style=""> </span>General Aviation News, July 31, 1988.</span></span></p> <p class="MsoNormal" style="margin-left: 0.5in;"><span style="font-family:Times New Roman;font-size:85%;"><span style="font-size: 10pt;">74.<span style="font-family:Times New Roman;font-size:78%;"><span style="font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;"> </span></span></span></span><span style="font-size:85%;"><span style="font-size: 10pt;">Gaffney, C., Armed Forces Institute of Pathology, “Aspartame in Aviation.” Paper presented at the 57<sup>th</sup> Annual Scientific Meeting of the Aerospace Medical Association, April 1986.</span></span></p> <span style="font-family:Courier New;font-size:85%;color:black;"><span style="font-size: 10pt; color: black;">75.</span></span>Roberts, H.J., M.D. “New Pers<br /><br /><span style="font-size:100%;">I know that you might be wondering why did it take me so long to write about this; well,</span> <span style="font-size:100%;">I remember that I saw that blog years ago, unfortunately, there was something that was so important to me that there were many times where I put it first before my school work. Please do forgive me about that; especially because I am no longer distracted by it anymore.</span> </div></div></div></div></div>RelaxinPetehttp://www.blogger.com/profile/04012284384679242207noreply@blogger.com0